fda glp-1 warning october 2025 Beyond the Headlines: Letters to Compounders Tirzepatide vs. Semaglutide: What You

In a May 18, 2026 letter brief, Eli Lilly asked Judge Karen Spencer Marston to confirm that forthcoming summary judgment briefing on Issue 2 warning adequacy and preemption may reach all injuries pleaded in the Amended Master Complaint, rather than being confined to a narrower subset of gastrointestinal injuries

Short-term, low-dose steroids may cause minimal disruption, while chronic high-dose use significantly blunts GLP-1 efficacy

Semaglutide Injection starts at $149/mo with no membership fee, HSA/FSA eligible, and no insurance requiredmaking ongoing treatment accessible

The satiety effect is dose-dependent and typically begins within the first few weeks of treatment

Contrarian Buyers The r/stocks community drove the most analytical discussion, with the post Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lillys in trial accumulating 762 upvotes and 146 comments

When clinically appropriate, our Chandler providers may prescribe GLP-1 medications including semaglutide and tirzepatide as part of a physician-supervised weight loss program